Prof. Velimir Popsavin | Medicinal Chemistry | Best Researcher Award

Posted on by sciencefather

Prof. Velimir Popsavin | Medicinal Chemistry | Best Researcher Award 

Prof. Velimir Popsavin , University of Novi Sad , Serbia

Prof. Velimir Popsavin is a distinguished Serbian chemist and retired professor at the University of Novi Sad. Renowned for his contributions to bioorganic and medicinal chemistry, he specialized in the total synthesis of natural products and innovative methods in monosaccharide chemistry. Over his illustrious career, he published over 100 peer-reviewed articles and served as an ad hoc reviewer for prestigious journals like Tetrahedron and Bioorganic & Medicinal Chemistry. A member of the Serbian Academy of Sciences and Arts, Prof. Velimir Popsavin has left a profound impact on chemical research and education, mentoring countless students and fostering advancements in medicinal chemistry.

Professional Profile

Orcid

Scopus  

Summary of Suitability for Award:

Prof. Velimir Popsavin’s  groundbreaking research, prolific publication record, and international recognition make him a highly deserving candidate for the “Best Researcher Awards.” His contributions not only demonstrate excellence in research but also underline his role as a mentor and thought leader in advancing chemistry and medicinal sciences globally. His work on the total synthesis of natural products and the development of innovative synthetic methods in carbohydrate chemistry has advanced medicinal chemistry. As a full member of the Serbian Academy of Sciences and Arts and a respected peer reviewer for leading journals, he has significantly influenced the field.

🎓Education:

Prof. Velimir Popsavin holds a Ph.D., M.Sc., and B.Sc. in Chemistry from the University of Novi Sad, Faculty of Sciences. His doctoral research focused on advancements in organic synthesis. He pursued multiple prestigious fellowships, including a postdoctoral position at the University of Leeds, UK, where he contributed to groundbreaking studies in bioorganic chemistry. As a visiting scientist at the University of Leeds, he deepened his expertise in carbohydrate chemistry, and during his research stay at L. Kossuth University in Hungary, he collaborated on biochemical projects, expanding his knowledge of monosaccharide derivatives. His educational background, combined with international research exposure, established him as a pioneer in medicinal chemistry and synthetic chemistry.

🏢Work Experience:

Prof. Velimir Popsavin’s career at the University of Novi Sad spanned over four decades, beginning as a Teaching Assistant in 1975. He progressed to Assistant Professor in 1989, Associate Professor in 1994, and Full Professor in 1999. As a professor, he led courses and research in bioorganic and medicinal chemistry until his retirement in 2021. Beyond teaching, he actively mentored young chemists, guiding them through advanced research in natural product synthesis and carbohydrate chemistry. Prof. Popsavin also contributed significantly as a collaborator and advisor during his fellowships in the UK and Hungary. His unwavering dedication to teaching and research has left an indelible mark on chemical sciences.

🏅Awards:

Prof. Velimir Popsavin  is a Full Member of the Serbian Academy of Sciences and Arts, a recognition of his exceptional contributions to chemistry. He is a longstanding member of the Serbian Chemical Society and has been celebrated for his role as an ad hoc reviewer for prominent journals like Tetrahedron, Synlett, and Bioorganic & Medicinal Chemistry. His dedication to fostering global scientific collaboration has earned him widespread respect. As a researcher and mentor, his awards and accolades reflect his influence in shaping medicinal chemistry and synthetic methodologies.

🔬Research Focus:

Prof. Velimir Popsavin’s research centers on the total synthesis of natural products, where he has developed innovative synthetic pathways to bioactive molecules. In medicinal chemistry, his work focuses on creating new compounds for therapeutic applications. His expertise in carbohydrate chemistry includes pioneering methods for modifying monosaccharides to design novel drug molecules. With over 100 peer-reviewed publications, his studies explore catalytic processes, green chemistry, and stereoselective synthesis. Prof.  Velimir Popsavin’s research continues to inspire advancements in organic chemistry and biochemistry.

Publication Top Notes:

1. Synthesis and antiproliferative activity of (−)-cleistenolide, (6S)-cleistenolide and 4-substituted cleistenolide analogues
  • Citations: 0
2. First total synthesis of asperilactone B. Revision of absolute stereochemistry of asperilactones B and C
  • Citations: 0
3. Synthesis and biological activity of thiophene bioisosteres of natural styryl lactone goniofufurone and related compounds
  • Citations: 2
4. New dephenylated analogues of (-)-goniofufurone: optimization of synthesis from L-xylose
  • Citations: 0
5. Synthesis and antiproliferative activity of (5R)-cleistenolide and analogues
  • Citations: 1

 

 

Abdulrahman Almehizia | Drug Discovery | Best Researcher Award

Posted on by sciencefather

Prof. Abdulrahman Almehizia | Drug Discovery | Best Researcher Award

Professor at King Saud University, Saudi Arabia

Abdulrahman A. Almehizia, PhD, is a distinguished Professor of Medicinal Chemistry at King Saud University, Riyadh, Saudi Arabia. With a robust academic background and extensive experience in pharmaceutical sciences, Dr. Almehizia has made significant contributions to teaching, research, and leadership within the Department of Pharmaceutical Chemistry. His career includes pivotal roles such as Department Chair and Chairman of the Drug Exploration and Development Chair (DEDC). He holds a PhD in Pharmaceutical Sciences from the University of Pittsburgh and continues to shape the field through innovative research and academic mentorship.

Author Metrics

ORCID Profile

Google Scholar Profile

Scopus Profile

Dr. Almehizia’s impact in academia is underscored by his substantial author metrics. He maintains a notable h-index of 24 on Scopus and has an active presence on Google Scholar with a comprehensive profile of citations. His research output is documented through numerous publications in high-impact journals and several patents in medicinal chemistry and biotechnology.

  • Citations: 2149
  • h-index: 27
  • i10-index: 57

Education

Abdulrahman A. Almehizia completed his Bachelor of Science in Pharmaceutical Sciences at King Saud University, Riyadh, Saudi Arabia, in 2007. He pursued advanced studies in the United States, earning his Doctor of Philosophy (PhD) in Pharmaceutical Sciences with a focus on Medicinal Chemistry and Biotechnology from the University of Pittsburgh in 2015.

Research Focus

Dr. Almehizia’s research focuses on the intersection of medicinal chemistry, biotechnology, and drug development. His work spans the synthesis and characterization of novel therapeutic compounds, drug delivery systems, and the application of computational methods in pharmaceutical sciences. He is particularly interested in addressing healthcare challenges through innovative drug discovery and development approaches.

Professional Journey

Dr. Almehizia’s professional journey at King Saud University began in 2006 as a Teaching Assistant and has progressed through various academic ranks, including Assistant Professor, Associate Professor, and Professor in the Department of Pharmaceutical Chemistry. He has also served as Department Chair and currently holds the position of Chairman of the Drug Exploration and Development Chair (DEDC).

Honors & Awards

Throughout his career, Dr. Almehizia has received recognition for his academic and research contributions. He was awarded a Graduate Scholarship from King Saud University and has been honored with a Travel and Presenter Award for his participation in international scientific conferences. His achievements reflect his commitment to excellence in pharmaceutical sciences.

Publications Noted & Contributions

Dr. Almehizia’s research output includes a prolific list of publications in peer-reviewed journals, showcasing his expertise in medicinal chemistry, drug discovery, and biotechnology. His contributions extend to multiple patents, demonstrating innovation in the development of therapeutic agents and drug delivery systems.

Copper–Vit B3 MOF preparation, characterization and catalytic evaluation in a one-pot synthesis of benzoxanthenones with docking validation as anti H. pylori

Journal: RSC Advances, 2024

DOI: 10.1039/D4RA03468F

Contributors: Asma S. Al-Wasidi, Mahmoud Tarek, Gehad E. Said, Ahmed M. Naglah, Abdulrahman A. Almehizia, Tamer K. Khatab

Summary: This study focuses on the preparation and characterization of a Copper–Vitamin B3 Metal-Organic Framework (MOF) and its catalytic performance in the synthesis of benzoxanthenones. The research includes computational docking studies validating its potential as an anti-Helicobacter pylori agent.

In vitro biological studies and computational prediction-based analyses of pyrazolo[1,5-a]pyrimidine derivatives

Journal: RSC Advances, 2024

DOI: 10.1039/D4RA00423J

Contributors: Abdulrahman A. Almehizia, Wael M. Aboulthana, Ahmed M. Naglah, Ashraf S. Hassan

Summary: This article explores the biological activities of pyrazolo[1,5-a]pyrimidine derivatives through in vitro studies and computational predictions. It emphasizes the potential of these derivatives as pharmacologically active compounds.

Combined computational and synthetic strategies for the development of potent pyrazolo-pyridine derivatives as anticancer agents

Journal: Journal of Molecular Structure, 2024

DOI: 10.1016/j.molstruc.2024.138301

Contributors: Shahid Ayaz, Shankar Gupta, Rajveer Singh, Balak Das Kurmi, Abdulrahman A. Almehizia, Vivek Asati

Summary: Published in the Journal of Molecular Structure, this research integrates computational and synthetic approaches to develop pyrazolo-pyridine derivatives with potential anticancer properties, highlighting a multidisciplinary approach to drug discovery.

Niacin based MOF as efficient nano-catalyst in the synthesis of some new benzothiazoles and benzimidazoles as anti-Alzheimer (AChE inhibitors)

Journal: Journal of Molecular Structure, 2024

DOI: 10.1016/j.molstruc.2024.138462

Contributors: Gehad E. Said, Mahmoud Tarek, Asma S. Al-Wasidi, Ahmed M. Naglah, Abdulrahman A. Almehizia, Tamer K. Khatab

Summary: This study investigates the use of a niacin-based Metal-Organic Framework (MOF) as a nano-catalyst in the synthesis of benzothiazoles and benzimidazoles, focusing on their potential as anti-Alzheimer agents by inhibiting Acetylcholinesterase (AChE).

Determination of nanoparticle solubility through green nanonization process using machine learning approach: Computational modeling and optimization

Journal: Ain Shams Engineering Journal, 2024

DOI: 10.1016/j.asej.2024.102946

Contributors: Ahmad J. Obaidullah, Abdulrahman A. Almehizia

Summary: Published in the Ain Shams Engineering Journal, this research employs a machine learning approach for computational modeling and optimization of nanoparticle solubility, showcasing innovative techniques in nanotechnology.

Research Timeline

Over the years, Dr. Almehizia has established a comprehensive research timeline marked by significant milestones. Starting with his doctoral studies at the University of Pittsburgh, his research trajectory has evolved through various academic and leadership roles at King Saud University, where he continues to spearhead impactful projects in pharmaceutical sciences.

Collaborations and Projects

Dr. Almehizia actively collaborates with national and international researchers, fostering partnerships that enhance research outcomes and expand scientific knowledge in medicinal chemistry and biotechnology. His involvement in collaborative projects underscores his commitment to advancing pharmaceutical research on a global scale.

This structured overview provides a detailed portrait of Dr. Abdulrahman A. Almehizia’s academic journey, research contributions, and professional impact in the field of medicinal chemistry and pharmaceutical sciences.